Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.
about
The role of gadoxetic acid as a paramagnetic contrast medium in the characterization and detection of focal liver lesions: a reviewConsensus report from the 7th International Forum for Liver Magnetic Resonance ImagingSegmentation of hepatic vessels from MRI images for planning of electroporation-based treatments in the liver.Accuracy of [18F]FDG PET/MRI for the Detection of Liver MetastasesComparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta-analysis.Does the Gadoxetic Acid-Enhanced Liver MRI Impact on the Treatment of Patients with Colorectal Cancer? Comparison Study with ¹⁸F-FDG PET/CT.Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.Arterial Phase with CAIPIRINHA-Dixon-TWIST (CDT)-Volume-Interpolated Breath-Hold Examination (VIBE) in Detecting Hepatic MetastasesAn overview of imaging techniques for liver metastases management.Current evidence for the diagnostic value of gadoxetic acid-enhanced magnetic resonance imaging for liver metastasis.Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in colorectal liver metastasis: the radiologist's perspective.Non-invasive quantitative imaging of hepatocellular carcinoma growth in mice by micro-CT using liver-targeted iodinated nano-emulsions.Cost-effective imaging for resectability of liver lesions in colorectal cancer: an economic decision model.
P2860
Q26828543-078760EA-B46A-4655-B50D-75EB8B941E08Q28088807-274C119E-330A-48DC-AED6-E3192A5310CFQ30563308-A6AD5CE6-CF32-41F0-AA01-D354571B7697Q35763359-BAAD95AE-845A-4B73-8A97-5E98D8F6B4E0Q36147405-1E669B70-7AC4-47BA-BF33-3D0977FE2A7AQ36679686-DB46DA71-1430-4B76-8EF6-504AF5A0D596Q37487034-1283AF94-4E90-4D2F-A2CD-EE649D81AF2EQ37500425-75C4FFF7-2448-4BE7-AEB2-5708E4EF90EEQ38594431-A00D0CF7-7BEE-4F20-A6ED-4AF37B54F1C5Q38691844-132563E2-F7A9-4933-B046-E233E7CB2C0BQ38845323-4E6A6DAD-9A5C-4C3D-9CE7-0257498C217EQ42636955-6EF89FF4-3D3B-4D22-BDF3-B91AFA2A3D18Q47660165-230DD2F6-523A-4503-9C54-0D06736AE7FD
P2860
Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Diagnostic performance of MDCT ...... experience in a single centre.
@en
Diagnostic performance of MDCT ...... experience in a single centre.
@nl
type
label
Diagnostic performance of MDCT ...... experience in a single centre.
@en
Diagnostic performance of MDCT ...... experience in a single centre.
@nl
prefLabel
Diagnostic performance of MDCT ...... experience in a single centre.
@en
Diagnostic performance of MDCT ...... experience in a single centre.
@nl
P2093
P2860
P1476
Diagnostic performance of MDCT ...... experience in a single centre.
@en
P2093
C D Collins
D E Malone
J F Gerstenmaier
J Geoghegan
R G Gibney
S J Skehan
P2860
P2888
P304
P356
10.1007/S11845-012-0805-X
P577
2012-03-17T00:00:00Z